Symposium on Low-Dose Lithium for Treatment of Psychiatric & Neurological Disorders

Psychiatry Redefined to Host First-Ever Symposium on Low-Dose Lithium for Treatment of Psychiatric and Neurological Disorders

Psychiatry Redefined, an educational platform dedicated to the personalized, evidence-based treatment of mental illness, is hosting the first-ever online symposium about the use of low-dose, nutritional lithium as a safe, integrative treatment for psychiatric and neurological disorders.

“Low-Dose Lithium – The Mineral as Medicine” will take place online, April 17-18, 2021. The symposium features eight international speakers, composed of prominent researchers and clinicians with specific expertise in the clinical application of low-dose lithium.

Lithium remains underutilized and misunderstood in the field of medicine, but using this mineral may in fact be one of the most promising treatments available. Low-dose lithium has proven to be effective in a variety of applications, from treating Alzheimer’s, depression, traumatic brain injury, and Parkinson's, to preventing suicide.

Psychiatry Redefined recently received a special grant for this lithium symposium. As a result, they have reduced the registration price to just $99 before the "early bird" deadline on March 15, after which it will be $139. Psychiatry Redefined is grateful for this opportunity to make this event accessible to more healthcare and mental health professionals.

For all symposium details, including the schedule of presentations, speaker biographies, and registration, go to www.LithiumSymposium.com.